Glaukos Completes Enrollment in Pivotal U.S. Study of PRESERFLO™ MicroShunt for Advanced Primary Open-Angle Glaucoma Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company dedicated to developing innovative treatments for…
Arcus Biosciences and Summit Therapeutics Collaborate to Advance Novel Combination Therapy for Advanced Kidney Cancer Arcus Biosciences, Inc., a clinical-stage global biopharmaceutical company focused on developing innovative therapies for cancer…
Aptar Pharma’s Nanopharm Facility Earns MHRA GMP Certification, Strengthening Global Support for Inhaled and Nasal Drug Development Aptar Pharma, a global leader in drug delivery systems, dosing technologies, protection solutions,…
GCCL and GemPharmatech Form Strategic Alliance to Deliver Integrated Drug Discovery and Clinical Development Solutions GCCL, a South Korea-based provider of clinical trial sample analysis and central laboratory services, and…
Cancer Cell Diagnostics Launches CellSight™ DNA Comprehensive Genomic Profiling Test to Advance Precision Oncology Cancer Cell Diagnostics (CCDx) has announced the commercial launch of CellSight™ DNA, its next-generation comprehensive genomic…
Kairos Pharma and Bayer Partner to Advance Combination Therapy for Metastatic Prostate Cancer Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company focused on developing therapies that overcome cancer drug resistance, has…
N-Zyme Biomedical Secures $4.6 Million Series A Financing to Advance Phase 2 Clinical Programs for Novel Reflux Disease Therapy N-Zyme Biomedical has successfully completed its Series A financing round, raising…
bioAffinity Technologies and Pictor Partner to Advance Next-Generation Precision Diagnostics for Asthma and COPD bioAffinity Technologies, Inc., a biotechnology company focused on developing innovative cancer diagnostics and targeted therapeutics, has…
Arrowhead Pharmaceuticals Reports Positive Phase 3 Results for Plozasiran in Severe Hypertriglyceridemia, Demonstrating Significant Triglyceride Reduction and Lower Risk of Acute Pancreatitis Arrowhead Pharmaceuticals, Inc. has announced positive topline results…
Zoetis Launches Portela® in Canada and Europe, Introducing the First Long-Acting Anti-NGF Therapy for Feline Osteoarthritis Pain Zoetis Inc. has announced the commercial launch of Portela® (relfovetmab) across Canada and…
Johnson & Johnson Receives FDA De Novo Authorization for OTTAVA™ Robotic Surgical System, Marking a New Era in Robotic-Assisted Surgery Johnson & Johnson has achieved a major milestone in the…
Crysvita® Approved Across the EU for Infants Living with X-Linked Hypophosphataemia Kyowa Kirin EMEA, a wholly owned subsidiary of Kyowa Kirin Co., Ltd., has announced that the European Commission (EC)…